Aviance Capital Partners’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $32M | Buy |
146,965
+1,807
| +1% | +$401K | 3.74% | 3 |
|
|
2025
Q4 | $33.2M | Buy |
145,158
+388
| +0.3% | +$88.4K | 3.82% | 4 |
|
|
2025
Q3 | $33.5M | Buy |
144,770
+615
| +0.4% | +$125K | 3.98% | 4 |
|
|
2025
Q2 | $26.8M | Buy |
144,155
+852
| +0.6% | +$158K | 3.5% | 5 |
|
|
2025
Q1 | $30M | Buy |
143,303
+387
| +0.3% | +$75.2K | 4.22% | 2 |
|
|
2024
Q4 | $25.4M | Sell |
142,916
-180
| -0.1% | -$33.1K | 3.51% | 5 |
|
|
2024
Q3 | $28.3M | Buy |
143,096
+449
| +0.3% | +$83.8K | 3.73% | 2 |
|
|
2024
Q2 | $24.5M | Buy |
142,647
+1,006
| +0.7% | +$167K | 3.48% | 3 |
|
|
2024
Q1 | $25.8M | Buy |
141,641
+19,028
| +16% | +$3.28M | 3.83% | 2 |
|
|
2023
Q4 | $19M | Sell |
122,613
-2,704
| -2% | -$394K | 4.07% | 2 |
|
|
2023
Q3 | $18.7M | Sell |
125,317
-3,646
| -3% | -$535K | 4.2% | 2 |
|
|
2023
Q2 | $17.4M | Sell |
128,963
-31,196
| -19% | -$4.57M | 3.68% | 2 |
|
|
2023
Q1 | $25.5M | Sell |
160,159
-12,133
| -7% | -$1.85M | 5.68% | 2 |
|
|
2022
Q4 | $27.8M | Sell |
172,292
-1,264
| -0.7% | -$194K | 6.5% | 1 |
|
|
2022
Q3 | $23.3M | Sell |
173,556
-68
| -0% | -$9.76K | 5.78% | 2 |
|
|
2022
Q2 | $26.6M | Buy |
173,624
+14,164
| +9% | +$2.16M | 5.92% | 2 |
|
|
2022
Q1 | $25.9M | Buy |
159,460
+1,938
| +1% | +$282K | 4.75% | 2 |
|
|
2021
Q4 | $21.3M | Buy |
157,522
+1,156
| +0.7% | +$137K | 3.55% | 3 |
|
|
2021
Q3 | $16.9M | Buy |
156,366
+4,419
| +3% | +$505K | 2.98% | 4 |
|
|
2021
Q2 | $17.1M | Buy |
151,947
+3,796
| +3% | +$428K | 2.99% | 5 |
|
|
2021
Q1 | $16M | Buy |
148,151
+222
| +0.2% | +$23.7K | 3.1% | 3 |
|
|
2020
Q4 | $15.9M | Buy |
147,929
+679
| +0.5% | +$65.3K | 3.21% | 5 |
|
|
2020
Q3 | $12.9M | Buy |
147,250
+1,811
| +1% | +$170K | 2.9% | 6 |
|
|
2020
Q2 | $14.3M | Buy |
145,439
+122,360
| +530% | +$10.8M | 3.53% | 3 |
|
|
2020
Q1 | $1.76M | Sell |
23,079
-22,703
| -50% | -$1.93M | 0.55% | 44 |
|
|
2019
Q4 | $4.05M | Buy |
45,782
+1,494
| +3% | +$124K | 1.04% | 14 |
|
|
2019
Q3 | $3.35M | Buy |
44,288
+9,790
| +28% | +$671K | 0.99% | 14 |
|
|
2019
Q2 | $2.51M | Sell |
34,498
-285
| -0.8% | -$22.4K | 0.69% | 30 |
|
|
2019
Q1 | $2.8M | Sell |
34,783
-5,460
| -14% | -$447K | 0.8% | 19 |
|
|
2018
Q4 | $3.71M | Sell |
40,243
-2,185
| -5% | -$192K | 1.3% | 12 |
|
|
2018
Q3 | $4.01M | Sell |
42,428
-566
| -1% | -$53.7K | 0.97% | 15 |
|
|
2018
Q2 | $3.98M | Buy |
42,994
+54
| +0.1% | +$5.27K | 1.15% | 12 |
|
|
2018
Q1 | $4.06M | Buy |
42,940
+2,222
| +5% | +$244K | 1.23% | 13 |
|
|
2017
Q4 | $3.94M | Buy |
40,718
+145
| +0.4% | +$13.7K | 1.3% | 10 |
|
|
2017
Q3 | $3.6M | Sell |
40,573
-5,355
| -12% | -$408K | 1.22% | 12 |
|
|
2017
Q2 | $3.33M | Buy |
45,928
+9,690
| +27% | +$651K | 1.07% | 15 |
|
|
2017
Q1 | $2.36M | Sell |
36,238
-26
| -0.1% | -$1.64K | 0.86% | 25 |
|
|
2016
Q4 | $2.27M | Buy |
36,264
+26
| +0.1% | +$1.59K | 0.8% | 29 |
|
|
2016
Q3 | $2.29M | Buy |
36,238
+292
| +0.8% | +$18.9K | 0.81% | 33 |
|
|
2016
Q2 | $2.23M | Sell |
35,946
-1,789
| -5% | -$109K | 0.82% | 33 |
|
|
2016
Q1 | $2.15M | Buy |
37,735
+730
| +2% | +$40.7K | 0.75% | 29 |
|
|
2015
Q4 | $2.19M | Buy |
37,005
+22,187
| +150% | +$1.28M | 0.75% | 29 |
|
|
2015
Q3 | $806K | Buy |
14,818
+428
| +3% | +$27.9K | 0.33% | 97 |
|
|
2015
Q2 | $967K | Sell |
14,390
-35
| -0.2% | -$2.29K | 0.36% | 82 |
|
|
2015
Q1 | $844K | Hold |
14,425
| – | – | 0.31% | 99 |
|
|
2014
Q4 | $944K | Sell |
14,425
-200
| -1% | -$12.6K | 0.35% | 78 |
|
|
2014
Q3 | $845K | Sell |
14,625
-5,600
| -28% | -$311K | 0.32% | 93 |
|
|
2014
Q2 | $1.14M | Sell |
20,225
-358
| -2% | -$18.8K | 0.45% | 58 |
|
|
2014
Q1 | $1.06M | Sell |
20,583
-9,275
| -31% | -$469K | 0.45% | 59 |
|
|
2013
Q4 | $1.58M | Sell |
29,858
-88
| -0.3% | -$4.33K | 0.66% | 38 |
|
|
2013
Q3 | $1.34M | Buy |
29,946
+1,753
| +6% | +$77.7K | 0.63% | 40 |
|
|
2013
Q2 | $1.17M | Buy |
+28,193
| New | +$1.23M | 0.63% | 47 |
|
Other funds holding ABBV
VCM
VPM
Aviance Capital Partners's ABBV Position: Q1 2026 in Review
Aviance Capital Partners increased its AbbVie (ABBV) stake by 1.2% in Q1 2026, buying an estimated $401K and bringing the position to 146,965 shares worth $32M. The position accounts for 3.74% of the portfolio, ranked #3.
Aviance Capital Partners first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. The position peaked at $33.5M in Q3 2025. 4,077 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- Aviance Capital Partners held 146,965 shares of AbbVie worth $32M as of Q1 2026.
- Aviance Capital Partners bought 1,807 AbbVie shares in Q1 2026, an estimated $401K.
- AbbVie made up 3.74% of Aviance Capital Partners's portfolio in Q1 2026, its #3 holding.
- Aviance Capital Partners first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
- Aviance Capital Partners's AbbVie position peaked at $33.5M in Q3 2025.
- 4,077 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on Aviance Capital Partners's 13F filing for Q1 2026, filed 6 May 2026.